?Developmental Biology and Solid Tumor Program Despite recent advances in understanding the etiology of pediatric solid tumors, the overall survival rate has not significantly improved in over 2 decades. For children with recurrent solid tumors, the survival rate is below 30%, and long-term survivors have an increase in the burden of disease associated with the administration of curative therapies. Therefore, the goal of the Developmental Biology and Solid Tumor Program (DBSTP) is to improve the survival and quality of life of children with solid tumors by integrating basic, translational, and clinical research. Michael Dyer, Ph.D. (laboratory lead) and Alberto Pappo, M.D. (clinical lead) are responsible for the overall leadership, academic themes, and direction of the DBSTP. They meet weekly to coordinate the activities of the program, identify opportunities for clinical translation and plan clinical trials. In addition, they mentor faculty within the Division of Solid Tumors, identifying and removing barriers to successful collaboration among SJCCC members and investigators around the world who share their goal to improve survival and quality of life for children with solid tumors. DBSTP holds a weekly seminar series to provide a forum for every Program member to present their research as well as monthly working group meetings focused on thematic research areas. The DBSTP has 21 Full Members and 4 Associate (junior mentored) Members representing the Departments of Oncology, Chemical Biology and Therapeutics, Developmental Neurobiology, Radiation Oncology, Diagnostic Imaging, Global Pediatric Medicine, Cancer Center Administration, Pathology, Pharmaceutical Sciences, Surgery, Computational Biology and Immunology. Among the full members, 11 are MDs, 7 are PhDs and 3 are MD/PhDs. Thirteen new members have been recruited to the DBSTP over the past 5 years to strengthen the basic, translational, and clinical research programs aligned with the 4 thematic Working Groups (Immunotherapy, Precision Medicine, Rare Tumors and Recurrent Disease). Peer-reviewed cancer focused funding has increased by 60% from $2.5M to $4M and the DBSTP also has $1.3M in annual funding from foundations. Research from the DBSTP has resulted in 475 publications, of which 22.9% are intra-programmatic, 40.4% are inter- programmatic, and 68.2% are inter-institutional (with other NCI-designated Cancer Centers). Overall, interactions both within the Program and with other Programs increased substantially since 2013. Program members serve as principal investigators on 18 clinical trials and 26 COG or industry-sponsored trials. They contributed a total of 801 interventional enrollments (51 national, 730 institutional, and 20 industry).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA021765-41
Application #
9883749
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
41
Fiscal Year
2020
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Wang, Xusheng; Jones, Drew R; Shaw, Timothy I et al. (2018) Target-Decoy-Based False Discovery Rate Estimation for Large-Scale Metabolite Identification. J Proteome Res 17:2328-2334
Sabin, N D; Cheung, Y T; Reddick, W E et al. (2018) The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. AJNR Am J Neuroradiol 39:1919-1925
Brinkman, Tara M; Recklitis, Christopher J; Michel, Gisela et al. (2018) Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature. J Clin Oncol 36:2190-2197
Fuentes-Alabi, Soad; Bhakta, Nickhill; Vasquez, Roberto Franklin et al. (2018) The cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network. Cancer 124:391-397
Bouchard, Jill J; Otero, Joel H; Scott, Daniel C et al. (2018) Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol Cell 72:19-36.e8
Flerlage, Jamie E; Metzger, Monika L; Bhakta, Nickhill (2018) The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice? Blood 132:376-384
Hijano, Diego R; Siefker, David T; Shrestha, Bishwas et al. (2018) Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy. Sci Rep 8:11034
Follis, Ariele Viacava; Llambi, Fabien; Kalkavan, Halime et al. (2018) Regulation of apoptosis by an intrinsically disordered region of Bcl-xL. Nat Chem Biol 14:458-465
Zheng, Daniel J; Krull, Kevin R; Chen, Yan et al. (2018) Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 124:3220-3230
Fatima, Soghra; Zhou, Sheng; Sorrentino, Brian P (2018) Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage-tracing mouse model. Exp Hematol 65:29-33

Showing the most recent 10 out of 6764 publications